PAST EVENT

Psychedelics for Alcoholism

Live Q&A Panel with Clearmind's Management

December 8, 2021

Clearmind’s Management Answers Questions Related to the Potential Treatment for Alcohol Use Disorder and Binge Drinking Based on Its Psychoactive Molecule MEAI

SPEAKERS

Adi Zuloff-Shani, PhD

CEO, Clearmind

Dr. Adi Zuloff-Shani is a biomedical research and development executive with over 20 years of strategic and operational leadership in the healthcare industry, and a deep understanding of therapeutics development in heavily regulated environments.

Adjunct Prof. Mark Haden

VP Business Development, Clearmind

Previously the Executive Director of MAPS Canada for 10 years, Mark is an adjunct professor at the University of British Columbia's School of Population and Public Health, and has published on the issue of drug control policy and psychedelics. Mark also worked in the addictions field in counselling, supervisory and management positions for 28 years.

HOST

Shannon Smadella, MBA

Moderator

Shannon Smadella is an award-winning social entrepreneur and business strategist with deep experience across the psychedelic sector, including advocacy, policy, and organizational leadership. As Co-Executive Director of World Psychedelics Day, Director of the International Psychedelics Awareness Foundation, and former board member of MAPS Canada, she has contributed to hundreds of interviews with leaders in psychedelic research and policy, including as a speaker, moderator, host, and interviewer.

PARTNERSHIPS